Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia (AML-17)
Leukemia

About this trial
This is an interventional treatment trial for Leukemia focused on measuring adult acute monocytic leukemia (M5b), adult acute erythroid leukemia (M6), adult acute megakaryoblastic leukemia (M7), adult acute minimally differentiated myeloid leukemia (M0), adult acute myeloblastic leukemia with maturation (M2), adult acute myeloblastic leukemia without maturation (M1), adult acute myelomonocytic leukemia (M4), adult acute monoblastic leukemia (M5a), untreated adult acute myeloid leukemia, secondary acute myeloid leukemia, adult acute myeloid leukemia with 11q23 (MLL) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22)
Eligibility Criteria
DISEASE CHARACTERISTICS: Diagnosis of acute myeloid leukemia (AML) Bone marrow blasts at least 20% by bone marrow aspiration or biopsy FAB subtypes M0-M2 and M4-M7 No acute promyelocytic leukemia (FAB subtype M3) Previously untreated primary or secondary AML, including AML after myelodysplastic syndromes Hydroxyurea and/or corticosteroid therapy for no more than 14 days allowed No blast crisis of chronic myelogenous leukemia No AML supervening after other myeloproliferative diseases No active CNS leukemia PATIENT CHARACTERISTICS: Age 61 to 75 Performance status WHO 0-2 Life expectancy Not specified Hematopoietic WBC less than 30,000/mm^3 (pretreatment with hydroxyurea for no more than 14 days allowed) Hepatic Bilirubin no greater than 3 times upper limit of normal (ULN) Renal Creatinine no greater than 3 times ULN Cardiovascular No concurrent severe cardiovascular disease No arrhythmias requiring chronic treatment No congestive heart failure No symptomatic ischemic heart disease Pulmonary No severe pulmonary dysfunction (CTC grade 3-4) Other HIV negative No other uncontrolled infection No other concurrent malignant disease No severe concurrent neurological or psychiatric disease No prior alcohol abuse No psychological, familial, sociological, or geographical condition that would preclude study participation PRIOR CONCURRENT THERAPY: Biologic therapy No concurrent hematopoietic growth factors (filgrastim [G-CSF] or sargramostim [GM-CSF]) except for life-threatening infection due to neutropenia Chemotherapy See Disease Characteristics Endocrine therapy See Disease Characteristics Radiotherapy Not specified Surgery Not specified Other No prior enrollment in this trial
Sites / Locations
- A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung
- Allgemeines Krankenhaus - Universitatskliniken
- AZ Sint-Jan
- Institut Jules Bordet
- Hopital Universitaire Erasme
- Centre Hospitalier Universitaire Brugmann
- Universitair Ziekenhuis Antwerpen
- Hopital de Jolimont
- CHU Liege - Domaine Universitaire du Sart Tilman
- Centre Hospitalier Peltzer-La Tourelle
- Hopital Edouard Herriot
- Centre Antoine Lacassagne
- Hotel Dieu de Paris
- Klinikum der Albert - Ludwigs - Universitaet Freiburg
- Ruprecht - Karls - Universitaet Heidelberg
- Southwest German Cancer Center at Eberhard-Karls-University
- Universita Degli Studi di Bari
- Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi
- Azienda Sanitaria di Bolzano
- Ospedale Binaghi
- Ospedale Oncologico A. Businco
- Ospedale Ferrarotto
- Ospedale Regionale A. Pugliese
- Azienda Istituti Ospitalieri
- Universita di Ferrara
- Ospedale S. Antonio Abate
- Ospedale San Martino
- Universita degli Studi di Messina
- Azienda Ospedaliera Papardo
- Ospedale Civile Umberto I
- Azienda Ospedaliera - Universitaria di Modena
- Azienda Ospedaliera "A. Cardarelli"
- Federico II University Medical School
- Azienda Ospedaliera Maggiore Della Carita
- Azienda Ospedale S. Luigi at University of Torino
- Azienda Ospedaliera Policlinico Paolo Giaccone
- Ospedale Cervello
- Ospedale La Maddalena - Palermo
- Perugia Regional Cancer Center
- Azienda Ospedale - d "S. Salvatore"
- Ospedale Civile Pescara
- Ospedale Sant' Eugenio
- Libero Istituto Universitario Campus Bio-Medico
- Universita Degli Studi "La Sapeinza"
- Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore
- H. San Giovanni-Addolorata Hospital
- Istituto di Ematologia Universita - University di Sassari
- Policlinico G. B. Rossi - Borgo Roma
- Ospedale San Bortolo
- Jeroen Bosch Ziekenhuis
- Onze Lieve Vrouwe Gasthuis
- Leiden University Medical Center
- Universitair Medisch Centrum St. Radboud - Nijmegen
- Maxima Medisch Centrum - Veldhoven
- Hospital Escolar San Joao
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ARM A
ARM B
GO + MICE for remission induction followed by GO + mini-ICE for consolidation
MICE for remission induction followed by mini-ICE for consolidation